University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (morning panel discussion)
Restricted accessOtherFirst published online October, 2017
University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (morning panel discussion)
BretzFGalloPMaurerW. Adaptive designs: the Swiss Army knife among clinical trial designs?Clin Trials. Epub ahead of print 22March2017. DOI: 10.1177/1740774517699406.
2.
WathenJKThallPF. A simulation study of outcome adaptive randomization in multi-arm clinical trials. Clin Trials. Epub ahead of print 1February2017. DOI: 10.1177/1740774517692302.
3.
DuYWangXLeeJ. Simulation study for evaluating the performance of response-adaptive randomization. Contemp Clin Trials2015; 40: 15–25.
4.
BowdenJTrippaL. Unbiased estimation for response adaptive clinical trials. Stat Methods Med Res. Epub ahead of print 11August2015. DOI: 10.1177/0962280215597716.
5.
ParmerMSydesMRCaffertyFHet al. Testing many treatments within a single protocol over 10 years at MRC CTU at UCL Multi-arm, multi stage platform, umbrella and basket protocols. Clin Trials, 2017, Vol. 14(5) 451–461http://journals.sagepub.com/doi/full/10.1177/1740774517725697.
6.
ConnorJTBroglioKRDurkalskiVet al. The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study. Trials2015; 16: 72.
7.
ConnorJTElmJJBroglioKR; ESETT and ADAPT-IT Investigators. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol2013; 66: S130–S137.
8.
EmanuelEJWendlerDKillenJet al. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis2004; 189: 930–937.
9.
JoffeSEllenbergSS. Commentary on Hey and Kimmelman. Clin Trials2015; 12: 116–118.
10.
BartlettRHRoloffDWCornellRGet al. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics1985; 76: 479–487.
11.
BrownCHTen HaveTRJoBet al. Adaptive designs for randomized trials in public health. Annu Rev Public Health2009; 30: 1–25.
12.
ZelenM. Play the winner rule and the controlled clinical trial. J Am Stat Assoc1969; 325: 131–146.
13.
WareJH. Investigating therapies of potentially great benefit: ECMO. Stat Sci1989; 4: 298–306.
14.
BerryDA. Investigating therapies of potentially great benefit: ECMO: comment: ethics and ECMO. Stat Sci1989; 4: 306–310.
15.
KalbfleischJDPrenticeRL. The statistical analysis of failure time data. 2nd ed.Hoboken, NJ: Wiley, 2002.
16.
SimonNSimonR. Adaptive enrichment designs for clinical trials. Biostatistics2013; 14: 613–625.
17.
JennisonCTurnbullBW. Group sequential methods with applications to clinical trials. 1st ed. Boca Raton, FL: Chapman & Hall/CRC, 1999.
18.
KarrisonTGHuoDChappellR. A group sequential, response-adaptive design for randomized clinical trials. Control Clin Trials2003; 24: 506–522.
LuceBRConnorJTBroglioKRet al. Using Bayesian adaptive trial designs for comparative effectiveness research: a virtual trial execution. Ann Intern Med2016; 165: 431–438.
21.
DavisBRCutlerJAGordonDJet al. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens1996; 9: 342–360.
22.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA2002; 288: 2981–2997.
23.
ProschanMBrittainEKammermanL. Minimize the use of minimization with unequal allocation. Biometrics2011; 67: 1135–1141.
24.
WeinsteinSLDolanLAWrightJGet al. Effects of bracing in adolescents with idiopathic scoliosis. N Engl J Med2013; 369: 1512–1521.
25.
UnoHWeiLJHughesM. Effects of bracing in adolescents with idiopathic scoliosis. N Engl J Med2014; 370: 680–681.
26.
National Research Council (US) Panel on Handling Missing Data in Clinical Trials (eds). The prevention and treatment of missing data in clinical trials. Washington, DC: The National Academies Press, 2010.